Clinicopathologic features of incidental prostatic adenocarcinoma in radical cystoprostatectomy specimens
dc.contributor.buuauthor | Aytaç, Berna | |
dc.contributor.buuauthor | Vuruşkan, Hakan | |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Cerrahi Patoloji Anabilim Dalı. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Üroloji Anabilim Dalı. | tr_TR |
dc.contributor.researcherid | AAH-9746-2021 | tr_TR |
dc.contributor.scopusid | 56527372000 | tr_TR |
dc.contributor.scopusid | 6507328150 | tr_TR |
dc.date.accessioned | 2022-01-03T13:17:31Z | |
dc.date.available | 2022-01-03T13:17:31Z | |
dc.date.issued | 2011-07-20 | |
dc.description.abstract | Background: The aim of this study is to review all features of incidentally discovered prostate adenocarcinoma in patients undergoing radical cystoprostatectomy for bladder cancer. Methods: The medical charts of 300 male patients who underwent radical cystoprostatectomy for bladder cancer between 1997 and 2005 were retrospectively reviewed. The mean age of the patients was 62 (range 51-75) years. Results: Prostate adenocarcinoma was present in 60 (20%) of 300 specimens. All were acinar adenocarcinoma. Of these, 40 (66.7%) were located in peripheral zone, 20 (33.3%) had pT2a tumor, 12 (20%) had pT2b tumor, 22(36.7%) had pT2c and, 6 (10%) had pT3a tumor. Gleason score was 6 or less in 48 (80%) patients. Surgical margins were negative in 54 (90%) patients, and tumor volume was less than 0.5 cc in 23 (38.3%) patients. Of the 60 incidentally detected cases of prostate adenocarcinoma 40 (66.7%) were considered clinically significant. Conclusion: Incidentally detected prostate adenocarcinoma is frequently observed in radical cystoprostatectomy specimens. The majority are clinically significant. | en_US |
dc.identifier.citation | Aytaç, B. ve Vuruşkan, H. (2011). "Clinicopathologic features of incidental prostatic adenocarcinoma in radical cystoprostatectomy specimens". World Journal of Surgical Oncology, 9(81). | en_US |
dc.identifier.issn | 1477-7819 | |
dc.identifier.issue | 81 | tr_TR |
dc.identifier.pubmed | 21774802 | tr_TR |
dc.identifier.scopus | 2-s2.0-79960554118 | tr_TR |
dc.identifier.uri | https://doi.org/10.1186/1477-7819-9-81 | |
dc.identifier.uri | https://wjso.biomedcentral.com/articles/10.1186/1477-7819-9-81 | |
dc.identifier.uri | http://hdl.handle.net/11452/23827 | |
dc.identifier.volume | 9 | tr_TR |
dc.identifier.wos | 000293967400001 | |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.wos | SCIE | en_US |
dc.language.iso | en | en_US |
dc.publisher | Bmc | en_US |
dc.relation.journal | World Journal of Surgical Oncology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Oncology | en_US |
dc.subject | Surgery | en_US |
dc.subject | Bladder cancer | en_US |
dc.subject | Cystoprostatectomy | en_US |
dc.subject | Incidental | en_US |
dc.subject | Prostate cancer | en_US |
dc.subject | Transitional cell carcinoma | en_US |
dc.subject | Bladder cancer | en_US |
dc.subject | Urothelial carcinoma | en_US |
dc.subject | Cystectomy | en_US |
dc.subject | Prevalence | en_US |
dc.subject | Pathology | en_US |
dc.subject | Volume | en_US |
dc.subject.emtree | Prostate specific antigen | en_US |
dc.subject.emtree | Adult | en_US |
dc.subject.emtree | Aged | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Bladder cancer | en_US |
dc.subject.emtree | Cancer diagnosis | en_US |
dc.subject.emtree | Cancer patient | en_US |
dc.subject.emtree | Cystectomy | en_US |
dc.subject.emtree | Gleason score | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Major clinical study | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Medical record review | en_US |
dc.subject.emtree | Prostate adenocarcinoma | en_US |
dc.subject.emtree | Tissue section | en_US |
dc.subject.emtree | Tumor volume | en_US |
dc.subject.emtree | Adenocarcinoma | en_US |
dc.subject.emtree | Comparative study | en_US |
dc.subject.emtree | Differential diagnosis | en_US |
dc.subject.emtree | Follow up | en_US |
dc.subject.emtree | Incidental finding | en_US |
dc.subject.emtree | Metabolism | en_US |
dc.subject.emtree | Methodology | en_US |
dc.subject.emtree | Middle aged | en_US |
dc.subject.emtree | Pathology | en_US |
dc.subject.emtree | Prognosis | en_US |
dc.subject.emtree | Prostate tumor | en_US |
dc.subject.emtree | Prostatectomy | en_US |
dc.subject.emtree | Retrospective study | en_US |
dc.subject.mesh | Adenocarcinoma | en_US |
dc.subject.mesh | Aged | en_US |
dc.subject.mesh | Aged, 80 and over | en_US |
dc.subject.mesh | Diagnosis, differential | en_US |
dc.subject.mesh | Follow-up studies | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Incidental findings | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Middle aged | en_US |
dc.subject.mesh | Prognosis | en_US |
dc.subject.mesh | Prostate-specific antigen | en_US |
dc.subject.mesh | Prostatectomy | en_US |
dc.subject.mesh | Prostatic neoplasms | en_US |
dc.subject.mesh | Retrospective studies | en_US |
dc.subject.scopus | Cystectomy; Prostate-Specific Antigen; Urinary Bladder Neoplasms | en_US |
dc.subject.wos | Oncology | en_US |
dc.subject.wos | Surgery | en_US |
dc.title | Clinicopathologic features of incidental prostatic adenocarcinoma in radical cystoprostatectomy specimens | en_US |
dc.type | Article | |
dc.wos.quartile | Q4 (Oncology) | en_US |
dc.wos.quartile | Q3 (Surgery) | en_US |